▲ 0.30%
prev close
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Congressional Trades
21
All tracked trades
Members Trading
18
Unique members
Net Activity
+3
12 buys · 9 sells
Members Who Traded This Stock
21 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-01-16 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 170d ago | — | |
| 2025-12-03 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 229d ago | — | |
| 2025-10-24 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 267d ago | — | |
| 2025-09-25 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 273d ago | — | |
| 2025-09-04 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 292d ago | — | |
| 2025-04-15 | AMGNAmgen Inc | Sell | $15,001 - $50,000 | 433d ago | — | |
| 2025-04-08 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 440d ago | — | |
| 2025-02-24 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 500d ago | — | |
| 2025-02-11 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 336d ago | — | |
| 2024-12-06 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 562d ago | — | |
| 2024-10-23 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 190d ago | — | |
| 2024-08-07 | AMGNAmgen Inc | Buy | $50,001 - $100,000 | 701d ago | — | |
| 2024-08-07 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 384d ago | — | |
| 2024-01-02 | AMGNAmgen Inc | Sell | $15,001 - $50,000 | 912d ago | — | |
| 2023-10-24 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 986d ago | — | |
| 2023-03-06 | AMGNAmgen Inc | Sell | $1,001 - $15,000 | 1189d ago | — | |
| 2022-10-19 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 1350d ago | — | |
| 2022-09-26 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 1386d ago | — | |
| 2022-05-11 | AMGNAmgen Inc | Buy | $1,001 - $15,000 | 1497d ago | — | |
| 2021-03-04 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 1419d ago | — | |
| 2019-09-27 | AMGNAmgen Inc | Buy | $15,001 - $50,000 | 1077d ago | — |
2026-01-16
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
170d ago
2025-12-03
David J. Taylor
AMGN
Amount
$1,001 - $15,000
Filed
229d ago
2025-10-24
Marjorie Taylor Greene
AMGN
Amount
$1,001 - $15,000
Filed
267d ago
2025-09-25
Lisa McClain
AMGN
Amount
$1,001 - $15,000
Filed
273d ago
2025-09-04
Sheldon Whitehouse
AMGN
Amount
$1,001 - $15,000
Filed
292d ago
2025-04-15
Tommy Tuberville
AMGN
Amount
$15,001 - $50,000
Filed
433d ago
2025-04-08
Rob Bresnahan
AMGN
Amount
$1,001 - $15,000
Filed
440d ago
2025-02-24
Jefferson Shreve
AMGN
Amount
$15,001 - $50,000
Filed
500d ago
2025-02-11
Daniel Meuser
AMGN
Amount
$1,001 - $15,000
Filed
336d ago
2024-12-06
Virginia Foxx
AMGN
Amount
$1,001 - $15,000
Filed
562d ago
2024-10-23
Julia Letlow
AMGN
Amount
$1,001 - $15,000
Filed
190d ago
2024-08-07
C. Scott Franklin
AMGN
Amount
$50,001 - $100,000
Filed
701d ago
2024-08-07
Scott Scott Franklin
AMGN
Amount
$1,001 - $15,000
Filed
384d ago
2024-01-02
Michael C. Burgess
AMGN
Amount
$15,001 - $50,000
Filed
912d ago
2023-10-24
Greg Stanton
AMGN
Amount
$1,001 - $15,000
Filed
986d ago
2023-03-06
Josh Gottheimer
AMGN
Amount
$1,001 - $15,000
Filed
1189d ago
2022-10-19
Josh Gottheimer
AMGN
Amount
$1,001 - $15,000
Filed
1350d ago
2022-09-26
Earl Blumenauer
AMGN
Amount
$1,001 - $15,000
Filed
1386d ago
2022-05-11
Josh Gottheimer
AMGN
Amount
$1,001 - $15,000
Filed
1497d ago
2021-03-04
Carol Devine Miller
AMGN
Amount
$15,001 - $50,000
Filed
1419d ago
2019-09-27
Richard W. Allen
AMGN
Amount
$15,001 - $50,000
Filed
1077d ago
Recent News
Powered by Polygon.io
PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight
Could Pfizer Ultimately Be the Biggest Winner in the $100 Billion Weight-Loss Market?
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes
Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy
Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider
Trade Timeline
Congressional activity, newest first
David J. Taylor
2026-01-16 · Purchase
$1,001 - $15,000
David J. Taylor
2025-12-03 · Sale
$1,001 - $15,000
Marjorie Taylor Greene
2025-10-24 · Purchase
$1,001 - $15,000
Lisa McClain
2025-09-25 · Sale
$1,001 - $15,000
Sheldon Whitehouse
2025-09-04 · Sale
$1,001 - $15,000
Tommy Tuberville
2025-04-15 · Sale
$15,001 - $50,000
Rob Bresnahan
2025-04-08 · Sale
$1,001 - $15,000
Jefferson Shreve
2025-02-24 · Purchase
$15,001 - $50,000
Daniel Meuser
2025-02-11 · Sale
$1,001 - $15,000
Virginia Foxx
2024-12-06 · Purchase
$1,001 - $15,000
Julia Letlow
2024-10-23 · Purchase
$1,001 - $15,000
C. Scott Franklin
2024-08-07 · Purchase
$50,001 - $100,000
Scott Scott Franklin
2024-08-07 · Purchase
$1,001 - $15,000
Michael C. Burgess
2024-01-02 · Sale
$15,001 - $50,000
Greg Stanton
2023-10-24 · Sale
$1,001 - $15,000
Josh Gottheimer
2023-03-06 · Sale
$1,001 - $15,000
Josh Gottheimer
2022-10-19 · Purchase
$1,001 - $15,000
Earl Blumenauer
2022-09-26 · Purchase
$1,001 - $15,000
Josh Gottheimer
2022-05-11 · Purchase
$1,001 - $15,000
Carol Devine Miller
2021-03-04 · Purchase
$15,001 - $50,000
Richard W. Allen
2019-09-27 · Purchase
$15,001 - $50,000